Modulation of glucose-6-phosphatase translocase expression

Details for Australian Patent Application No. 2009201229 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Bhanot, Sanjay; Dobie, Kenneth W.

Agent Pizzeys

Pub. Number AU-B-2009201229

Parent 2005244764

Filing date 30 March 2009

Wipo publication date 23 April 2009

Acceptance publication date 2 August 2012

International Classifications

A61K 31/70 - Carbohydrates

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

23 April 2009 Application Open to Public Inspection

  Published as AU-B-2009201229

23 April 2009 Complete Application Filed

2 August 2012 Application Accepted

  Published as AU-B-2009201229

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201230-Method and device for stacking packaged food slices

2009201228-Real ear measurement adaptor with internal sound conduit